Columbia Sportswear Company Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments And Risk Management (Tables)

6 Months Ended

Jun. 30, 2015

The following table presents the gross notional amount of outstanding derivative instruments (in thousands):



	June 30, 2015		December 31, 2014		June 30, 2014
Derivative instruments designated as cash flow hedges:
Currency forward contracts	$	95,000	$	103,000	$	127,000
Derivative instruments not designated as cash flow hedges:
Currency forward contracts	117,000		128,000		63,500

The following table presents the balance sheet classification and fair value of derivative instruments (in thousands):



	Balance Sheet Classification	June 30, 2015		December 31, 2014		June 30, 2014
Derivative instruments designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	$	4,485	$	9,993	$	986
Currency forward contracts	Other non-current assets	320		—		155
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	28		—		1,081
Currency forward contracts	Other long-term liabilities	—		—		12
Derivative instruments not designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	4,458		2,754		302
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	738		924		650

The following table presents the statement of operations effect and classification of derivative instruments (in thousands):



	Statement of Operations Classification	Three Months Ended June 30,						Six Months Ended June 30,
	Statement of Operations Classification	2015			2014			2015			2014
Currency Forward and Option Contracts:
Derivative instruments designated as cash flow hedges:
Gain (loss) recognized in other comprehensive income or loss	—	$	(742	)	$	(634	)	$	4,840		$	70
Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion	Cost of sales	1,690			690			3,947			1,499
Loss recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Net sales	(2		)	—			(17		)	—
Loss recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Cost of sales	(88		)	(186		)	(210		)	(208		)
Derivative instruments not designated as cash flow hedges:
Gain (loss) recognized in income	Other non-operating expense	(356		)	(506		)	2,580			(1,971		)